EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities

Sahar Jalilivand, Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Mehrdad Izadirad, Fatemeh Mikanik, Ahmad Gharehbaghian

Clinical and Experimental Medicine · 11.11.2025 · 25 (1)

DOI: 10.1007/s10238-025-01908-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 11.11.2025. Verfasst von Sahar Jalilivand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Hematology and Blood Bank, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Drug Resistance, Neoplasm, Hematologic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) plays a critical role at all stages of tumor progression. Cancer-associated fibroblasts (CAFs), as the main components of this environment, display diversities in origin, phenotype, and function, which contribute to cancer progression by regulating the tumor cell biology via cell-cell contact, releasing numerous regulatory elements such as growth factors (GFs), cytokines, and chemokines, and even remodeling the extracellular matrix (ECM). In this Review, we discuss the current understanding of CAFs' pro- or anti-tumor functions in various hematological malignancies, including acute and chronic leukemia, lymphoma, and multiple myeloma (MM). The accumulating evidence highlighted that CAFs not only are implicated in these neoplasms' initiation, development, and metastasis but also are involved in chemoresistance to various chemotherapy drugs such as daunorubicin and bortezomib. Intriguingly, cell culture-based methods' results outlined that targeting signaling pathways that are used by CAFs to exert their pro-tumorigenic effects could be exploited in favor of tumor inhibition, which requires more investigation. Therefore, this therapeutic approach should be considered in future studies to develop a novel targeted therapy in hematological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsDrug Resistance, NeoplasmHematologic NeoplasmsHumansTumor MicroenvironmentAntineoplastic AgentsDisease ProgressionSignal TransductionAnimals

Stichwörter der Autor:innen

Cancer-associated fibroblastHematological malignanciesProgressionTreatmentTumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Laboratory Hematology and Blood Bank, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Student Research Committee, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Laboratory Hematology and Blood Bank Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Jalilivand, S., Yazdanparast, S., Bakhtiyaridovvombaygi, M., Izadirad, M., Mikanik, F., & Gharehbaghian, A. (2025). The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities. Clinical and Experimental Medicine, 25(1). https://doi.org/10.1007/s10238-025-01908-4

Vancouver

Jalilivand S, Yazdanparast S, Bakhtiyaridovvombaygi M, Izadirad M, Mikanik F, Gharehbaghian A. The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities. Clinical and Experimental Medicine. 2025;25(1). doi:10.1007/s10238-025-01908-4

BibTeX
@article{Jalilivand2025,
  author = {Jalilivand, Sahar and Yazdanparast, Somayeh and Bakhtiyaridovvombaygi, Mehdi and Izadirad, Mehrdad and Mikanik, Fatemeh and Gharehbaghian, Ahmad},
  title = {The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities},
  journal = {Clinical and Experimental Medicine},
  year = {2025},
  volume = {25},
  number = {1},
  doi = {10.1007/s10238-025-01908-4}
}
Kostenlos starten →